These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect. Leighton PC; Kitau MJ; Chard T; Gordon YB; Leek AE Lancet; 1975 Nov; 2(7943):1012-5. PubMed ID: 53498 [TBL] [Abstract][Full Text] [Related]
45. Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein. Simpson JL; Elias S; Morgan CD; Andersen RN; Shulman LP; Sibai BM; Mercer BM; Skoll A Am J Obstet Gynecol; 1991 Mar; 164(3):829-36. PubMed ID: 1706141 [TBL] [Abstract][Full Text] [Related]
46. Raised alpha-fetoprotein levels in amniotic fluid and maternal serum in a triplet pregnancy in which one fetus had an omphalocoele. Nevin NC; Armstrong MJ Br J Obstet Gynaecol; 1975 Oct; 82(10):826-8. PubMed ID: 53068 [TBL] [Abstract][Full Text] [Related]
48. [Prenatal detection of embryofetal malformations through the analysis of amniotic fluid, especially determination of alpha 1-fetoprotein]. Lambotte C Rev Med Liege; 1975 May; 30(9):303-4. PubMed ID: 49072 [No Abstract] [Full Text] [Related]
50. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055 [TBL] [Abstract][Full Text] [Related]
51. Changes in alpha-fetoprotein levels in a case with multiple congenital anomalies. Lau HL; Heller RH; Goscin S; Winn K; Linkins SE Am J Obstet Gynecol; 1977 May; 128(2):225-6. PubMed ID: 67807 [TBL] [Abstract][Full Text] [Related]
52. Maternal serum alpha-fetoprotein in normal pregnancy. Hay DM; Forrester PI; Hancock RL; Lorscheider FL Br J Obstet Gynaecol; 1976 Jul; 83(7):534-8. PubMed ID: 60124 [TBL] [Abstract][Full Text] [Related]
53. Diagnostic use of meternal serum alpha-fetoprotein levels. Cowchock FS; Jackson LG Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892 [TBL] [Abstract][Full Text] [Related]
57. Radioimmunoassay of maternal serum -fetoprotein associated with pregnancy. Ishiguro T; Nishimura T Am J Obstet Gynecol; 1973 May; 116(1):27-33. PubMed ID: 4121367 [TBL] [Abstract][Full Text] [Related]
58. Effect of gestational age on screening for neural-tube defects by maternal plasma-A.F.P. measurement. Brock DJ; Scrimgeour JB; Bolton AE; Wald N; Peto R; Barker S Lancet; 1975 Aug; 2(7927):195-6. PubMed ID: 51957 [TBL] [Abstract][Full Text] [Related]
59. [Significance of serum alpha fetoprotein and immunoglobulin G concentrations as a parameter of gestational-age examination in abnormalities and twins]. Stück B; Vajaradul C; Oberbeck F Monatsschr Kinderheilkd (1902); 1975 May; 123(5):435-7. PubMed ID: 56706 [No Abstract] [Full Text] [Related]
60. The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters. Lockwood CJ; Lynch L; Ghidini A; Lapinski R; Berkowitz G; Thayer B; Miller WA Am J Obstet Gynecol; 1993 Nov; 169(5):1190-7. PubMed ID: 7694466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]